USA
Meldepflichtige Eigengeschäfte von Führungskräften (Directors' Dealings) gemäß Art. 19 MAR – wer im eigenen Unternehmen kauft und verkauft.
Datenstand: 23.10.2026 (gestern)
| Gemeldet ↓ | Geschäft | Unternehmen | Insider | Position | Art | Volumen |
|---|---|---|---|---|---|---|
| 14.10.2026 | 15.10.2026 | Ferguson Enterprises Inc. | Robert Anthony Camposano Jr. | Senior VP - Waterworks | Verkauf | 41.532,50 USD |
| 14.10.2026 | 14.10.2026 | Ferguson Enterprises Inc. | Robert Anthony Camposano Jr. | Senior VP - Waterworks | Verkauf | 44.346,63 USD |
| 14.10.2026 | 14.10.2026 | Baozun Inc. | Wenbin Qiu | Chief Executive Officer / Director | Kauf | 19.952,00 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 21.840,00 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 261.830,02 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 261.288,91 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 217.261,80 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 478.644,37 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 1.044.509,05 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 1.081.544,26 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 283.023,14 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 606.326,34 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 340.038,61 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 214.356,12 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 128.311,99 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 21.299,20 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 63.742,40 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 84.814,00 USD |
| 14.10.2026 | 14.10.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 21.042,80 USD |
| 14.10.2026 | 14.10.2026 | American Integrity Insurance Group, Inc. | Robert C. Ritchie | Chief Executive Officer / Director | Verkauf | 719.852,28 USD |
| 14.10.2026 | 14.10.2026 | Terrestrial Energy Inc. 🔥 Cluster | Charles G. Pardee | Director | Kauf | 22.125,00 USD |
| 14.10.2026 | 14.10.2026 | Digi Power X Inc. | Michel Amar | Chief Executive Officer / Director / 10% Owner | Kauf | 55.256,00 USD |
| 14.10.2026 | 14.10.2026 | Bluerock Private Real Estate Fund 🔥 Cluster | Jordan B. Ruddy | President | Kauf | 44.316,80 USD |
| 14.10.2026 | 14.10.2026 | Guardant Health, Inc. | Alex M. Azar II | Director | Verkauf | 11.032,41 USD |
| 14.10.2026 | 14.10.2026 | Ellsworth Growth & Income Fund Ltd. | Saba Capital Management, L.P. | 10% Owner | Kauf | 658.414,42 USD |
| 14.10.2026 | 14.10.2026 | Mexico Equity & Income Fund Inc. | Saba Capital Management, L.P. | 10% Owner | Kauf | 254.285,08 USD |
| 14.10.2026 | 14.10.2026 | Qualys, Inc. | Sumedh S. Thakar | CEO & PRESIDENT / Director | Verkauf | 77.721,00 USD |
| 14.10.2026 | 14.10.2026 | Qualys, Inc. | Sumedh S. Thakar | CEO & PRESIDENT / Director | Verkauf | 96.419,40 USD |
| 14.10.2026 | 14.10.2026 | Qualys, Inc. | Sumedh S. Thakar | CEO & PRESIDENT / Director | Verkauf | 75.994,00 USD |
| 14.10.2026 | 14.10.2026 | Qualys, Inc. | Sumedh S. Thakar | CEO & PRESIDENT / Director | Verkauf | 283.803,00 USD |
| 14.10.2026 | 14.10.2026 | Qualys, Inc. | Sumedh S. Thakar | CEO & PRESIDENT / Director | Verkauf | 75.210,16 USD |
| 14.10.2026 | 14.10.2026 | Micron Technology Inc. | Michael Charles Ray | SVP, Chief Legal Officer | Verkauf | 37.891,60 USD |
| 14.10.2026 | 14.10.2026 | Hims & Hers Health, Inc. | Soleil Boughton | Chief Legal Officer | Verkauf | 100.576,66 USD |
| 14.10.2026 | 15.10.2026 | Venture Global, Inc. | Keith D. Larson | General Counsel and Secretary | Verkauf | 4.842.463,00 USD |
| 14.10.2026 | 14.10.2026 | Venture Global, Inc. | Keith D. Larson | General Counsel and Secretary | Verkauf | 5.282.001,30 USD |
| 14.10.2026 | 14.10.2026 | Borr Drilling Ltd. | Tor Olav Troim | Director | Kauf | 3.542.550,00 USD |
| 14.10.2026 | 14.10.2026 | Prosperity Bancshares Inc. | Ned S. Holmes | Director | Verkauf | 6.622,17 USD |
| 14.10.2026 | 14.10.2026 | Prosperity Bancshares Inc. | Ned S. Holmes | Director | Verkauf | 3.197,76 USD |
| 14.10.2026 | 14.10.2026 | Prosperity Bancshares Inc. | Ned S. Holmes | Director | Verkauf | 29.916,57 USD |
| 14.10.2026 | 14.10.2026 | Prosperity Bancshares Inc. | Ned S. Holmes | Director | Verkauf | 33.108,60 USD |
| 14.10.2026 | 14.10.2026 | Zone Frontier Inc. | Tyler Lewis Hassen | Chief Executive Officer / Director | Kauf | 85.200,00 USD |
| 14.10.2026 | 14.10.2026 | Nurix Therapeutics, Inc. | Julia P. Gregory | Director | Verkauf | 528.528,02 USD |
| 14.10.2026 | 14.10.2026 | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer / Director | Kauf | 8.576,00 USD |
| 14.10.2026 | 14.10.2026 | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer / Director | Kauf | 208.333,04 USD |
| 14.10.2026 | 14.10.2026 | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer / Director | Kauf | 205.889,14 USD |
| 14.10.2026 | 14.10.2026 | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer / Director | Kauf | 8.576,00 USD |
| 14.10.2026 | 14.10.2026 | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer / Director | Kauf | 209.948,02 USD |
| 14.10.2026 | 14.10.2026 | Inhibrx Biosciences, Inc. | Mark Lappe | Chief Executive Officer / Director | Kauf | 207.654,63 USD |
| 14.10.2026 | 14.10.2026 | Nordson Corp. | Milton Mayo Morris | Director | Verkauf NDSN | 83.436,00 USD |
| 14.10.2026 | 14.10.2026 | Formfactor Inc. | Mike Slessor | CEO / Director | Verkauf | 151.104,00 USD |